Biologics Safety Testing Market worth $6.8 billion | Opportunities, Key Players, Competitive and Regional Analysis
The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growing developments of biologics and biosimilars, increased concerns over the cell culture contamination, and rising investments in biopharmaceutical...
Biologics Safety Testing Market: Leading Companies – Exclusive Report by MarketsandMarkets™
Global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities...
Biologics Safety Testing Market Worth USD 6.2 billion by 2026 (At A CAGR Of 12.4%)
What This Report Will Provide?
The biologics safety testing industry is constantly evolving with advancements in technologies and the development of new and improved safety testing programs across various industries. Highly skilled professionals are required to keep pace with the continuing changes in analytical technologies and safety testing methodologies.
Expected Revenue Growth:
[185...
Biologics Safety Testing Market – Trend, Scope, Size, Share, Analysis
The biologics
safety testing market was valued at USD 2.75 Billion in 2017 and is
expected to grow at a CAGR of 12.2% to reach USD 4.90 Billion in 2022.
Growth in pharmaceutical and biotechnology industry driven
by government support in both industries, the positive trend of R&D
investment in the life sciences industry and an increase in the number of new
drug launches are the major factors...